CERULYSE
CHAUVIN
Identification
- Active ingredient (INN)
- XYLENE
- Internal code
- 18 D 016
- Country of Origin
- France
- Pharmaceutical form
- Otic Solution
- Prescription List
- OTC
- Packaging
- flacon/10ml
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
Extraction of cerumen caps.
Associated Conditions
In case of tympanic destruction, intraatrial administration may put the product in contact with the middle ear structures and cause adverse reactions at their level.
Mechanism of Action
Pharmacotherapeutic group
CERUMENOLYTIC (S: Sensal Organs), ATC code: S02DC.
Xylene is a lipophilic solvent, it facilitates the removal of the cerumen stopper by dissolving it.
Adverse Effects
Possible local allergic reactions, irritation.
Reporting suspected adverse reactions
Reporting suspected adverse reactions after authorization of the drug is important.
It allows for continuous monitoring of the benefit/risk of the drug.
Health professionals report any suspected adverse reactions via the national reporting system: National Agency for the Safety of Drugs and Health Products (ANSM) and the Network of Regional Pharmacovigilance Centres.
Warnings
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if tamper evident seal is broken or missing.
Store in a cool, dry place.
Dosage & Administration
Adults and children to 10 drops orally, 3 times daily or as otherwise directed by a health care porfessional.
If symptoms persist for more than 7 days, consult your health care professional.
Consult a physician for use in children under 12 years of age.